Potential treatments for COVID-19

4. Remdesivir

Remdesivir is an antiviral medication developed by US biotechnology company Gilead Sciences as a treatment for Ebola. It is not being tested as a potential COVID-19 treatment.

Cao Bin, who leads the trials in China, said studies have shown that Remdesivir is effective in arresting the growth of the coronavirus in vitro, which means the procedure was conducted in a controlled environment outside of a living organism.